| Name | Title | Contact Details |
|---|
Aclaris Therapeutics, Inc. is a specialty pharmaceutical company focused on the development of a topically applied therapy directed toward the removal of seborrheic keratosis (SK) and other verrucoid lesions of the skin.
ForSight VISION5, Inc. (www.forsightvision5.com), was founded in January of 2011 as the fifth company to emerge from the ophthalmic incubator ForSight Labs, LLC (www.forsightlabs.com). ForSight VISION5 is focused on developing non-invasive drug delivery products that replace eye drops and provide sustained therapy for major anterior segment eye diseases including glaucoma, dry eye, and allergy. ForSight VISION5`s lead product candidate is the Helios insert, a novel, non-invasive delivery system designed to allow glaucoma and ocular hypertensive patients to receive medication continually. The Helios insert is restricted to investigational use only and has not been approved by the Food and Drug Administration or any other regulatory authority for commercial distribution.
Capsalus Corp. is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ridgewood Nursing Ctr is a Bedford, NH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Ncd Medical Corp is a Eastlake, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.